NCT02397434View on ClinicalTrials.gov

Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 1, 2014

Primary Completion Date

October 30, 2018

Study Completion Date

October 30, 2028

Conditions
Toxicity
Interventions
RADIATION

Adjuvant EBRT

Radiation up to a median dose of 50 Gy in 25 fractions will be delivered with IMAT to the pelvic lymph node regions. If there is a positive surgical margin, the operative bladder bed will be included in the radiation field. A simultaneous integrated boost to positive lymph nodes will be delivered.

Trial Locations (1)

9000

Dept of Radiotherapy, University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT02397434 - Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter